We organized a webinar named “Innovative Approaches to Drug Repositioning: The Cloudscreen® Platform” where our one-stop-shop drug repurposing platofrm was presented.
Drug repurposing, Big Data & Artificial Intelligence
Lay science article about drug repurposing published in InScience Magazine. Drug repurposing significantly accelerates the discovery and development of drugs with a substantial impact on rare diseases. In collaboration with big data and artificial intelligence (AI) technologies, it enhances the reliability of predictions, regarding the effectiveness, but also the toxicity of the repurposed drug. Modern computational tools now guide and enrich laboratory approaches, while the latter validate working hypotheses or create new ones. A typical example of innovative synergies is the drug repositioning platform Cloudscreen©, an innovation product of Cloudpharm PC, a Greek start-up company, and the Biomarker Discovery & Translational Research Laboratory of the National Research Foundation.
Presenting Cloudscreen at the Repo4EU on tour event in Athens
Repo4EU is an EU funded project with the aim of building the Euro-Global Platform for Mechanism-based Drug Repurposing. Learn more here
Through the course of the Repo4EU national dissemination journey, at their stop in Greece we were invited to present our repurposing platofrm CLOUDSCREEN.
Cloudscreen presentation at the entrepreneurship festival GRBossible “In Action”
POSTERS PRESENTATIONS AT 72nd Annual Conference of the Hellenic Society of Biochemistry and Molecular Biology
Cloudscreen presentation at Neo4j Online Developer Education Summit 2022
CLOUDSCREEN AT BEYONDEXPO
Cloudscreen at Pfizer’s Start4Health challenge
Posters presentations at EACR 2022 Congress – Innovative Cancer Science: Translating Biology to Medicine
Modelling missense mutations on druggable proteins for computational drug repurposing
Poster presenation at the International E-conference on Bioinformatics 2022